Current studies

  • TRICCHOME

    Duration: 24 months
    Recruitment:Ongoing
    Age:18 to 24 years old

    Participants wanted:

    Young adults aged 18 to 24 years old who regularly consume cannabis or who consume cannabis daily.
    .

    To access the pre-screening form: https://redcap.chumontreal.qc.ca/redcap/surveys/?s=EFYM9L33XD4N4AK7

    read study
  • ASCME Project

    Duration: Up to 24 weeks
    Recruitment:In progress
    Age:18 to 55 years old

    Participants wanted:

    Adults between the ages of 18 and 55 years old who are regular users of methamphetamine (meth, crystal meth, tina) and want to cut down or stop use 

    read study
  • SPECTRE Project

    Duration: 20 months
    Recruitment:In progress
    Age:Between 21 and 49 years old

    Participants wanted:

    Be healthy, between the ages of 21 and 49, have used cannabis at least once in your life, and are currently an occasional cannabis user.

    read study
  • HEPCO Study

    Duration: visits every three months (20 min to 2h) for an unlimited period
    Recruitment:In progress
    Age:18 years and over

    Participants wanted:

    Men and women consuming injection drugs (in the last 6 months)
    .

    read study
    seringue fond vert
  • ECHO Study

    Duration: 24 months
    Recruitment:In progress
    Age:18 years and over

    Participants wanted:

    Quebec health and social services professionals and clinicians who are enrolled in the ECHO®CHUM concurrent disorders training program.

    read study

Recently completed studies

  • Comprehension Project

    Duration: A 90-minute group discussion
    Recruitment:Finished
    Age:16 to 65 years old

    Participants wanted:

    People aged 16 to 65 who have experienced or are experiencing psychosis and use cannabis regularly OR People aged 18 to 65 who have a relative in this situation

    read study
    CATEGORY: Cannabis
  • iCanChange (iCC)

    Duration: 12 weeks
    Recruitment:Ongoing, ending January 2024
    Age:18 to 35 years old

    Participants wanted:

    Young adults between ages 18-35, diagnosed with psychosis and cannabis use disorder, receiving early intervention services for psychosis.

    read study
  • CHAMPS

    Duration: 18 weeks
    Recruitment:Ended June 2023
    Age:18 to 35 years old

    Participants wanted:

    Young adult participants between ages 18 and 35 with early psychosis who use cannabis and are open to changing their cannabis-related practices.

    read study
  • CANNABINOIDS studies

    Duration: 5 visits spaced at least one week
    Recruitment:Ongoing, ending in summer 2023
    Age: 21 to 65 years old

    Participants wanted:

    Have used cannabis at least once in their life, be in good health, willing to use the research product during the study.

    read study
  • DEP-TAO survey

    Duration: One 45-to-60-min visit
    Recruitment:From May to December 2019
    Age:18 to 75 years

    Participants wanted:

    Men and women under agonist treatment (methadone, suboxone) with depressive symptoms.
    .

    read study
  • CBD-Cocaine

    Duration: 92 days
    Recruitment:From July 2016 to June 2019
    Age:18 to 65 years

    Participants wanted:

    Men and women consuming cocaine wishing to take medication during the study.
    .

    read study
  • OPTIMA Study

    Duration: 24 to 28 weeks
    Recruitment: Completed in March 2020
    Age:18 to 64 years

    Participants wanted:

    Men and women consuming opioids and wishing to access a substitution treatment.
    .

    read study
  • SPICE surveys

    Duration: One 30-min visit
    Recruitment:Until the end of April 2020
    Age:18 to 35 years

    Participants wanted:

    Men and women consuming cannabis and followed in the clinic for first psychotic episodes since at least two months.

    read study

Future Studies

Future studies

Projet CBD-INHALÉ (à venir): Randomized, triple-blind, crossover, placebo-controlled study of the effects of low-dose inhaled cannabidiol in healthy occasional cannabis users

Projet TRICCHOME (coming soon), Research project aimed at understanding patterns of frequent cannabis use through the use of a mobile application.